Finance

Beta
Lists
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
$3.60
+3.15%
(+0.11) 1D
$3.68
+2.22% (+0.080)
Pre-market
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
$3.50
High
$3.71
Low
$3.49
Mkt. cap
277.88M
Avg. vol.
1.22M
Volume
0.00
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.83
Beta
0.94
Shares outstanding
77.19M
No. of employees
33
Open
$3.50
High
$3.71
Low
$3.49
Mkt. cap
277.88M
Avg. vol.
1.22M
Volume
0.00
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.83
Beta
0.94
Shares outstanding
77.19M
No. of employees
33
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ELDN in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current $3.60
$10.00 (+177.78%)
Average
$8.00 (+122.22%)
Lowest
$6.00 (+66.67%)
News stories
From sources across the web
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteeledon.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.28M
14.97M
17.49M
17.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.46M
4.10M
3.99M
3.98M
Operating expense
24.73M
19.07M
21.48M
21.18M
Total operating expenses
24.73M
19.07M
21.48M
21.18M
Operating income
-24.73M
-19.07M
-21.48M
-21.18M
Other non operating income
13.52M
1.61M
11.07M
-17.84M
EBT including unusual items
-11.22M
-17.46M
-10.41M
-39.02M
EBT excluding unusual items
-11.22M
-17.46M
-10.41M
-39.02M
Income tax expense
-
-
35.00K
-
Effective tax rate
-
-
-0.34%
-
Other operating expenses
-
-
-
-
Net income
-11.22M
-17.46M
-10.45M
-39.02M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.21
-0.10
-0.33
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more